cDNA microarray analysis of vascular gene expression after nitric oxide donor infusions in rats: Implications for nitrate tolerance mechanisms

AAPS PharmSci

Volumn 4, Issue 2, 2002, Pages

  Wang, Ellen Q ^a   Lee, Woo In ^a   Brazeau, Daniel ^a   Fung, Ho Leung ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

DNA microarray; Gene regulation; Nitrate tolerance; Nitric oxide donor; Nitroglycerin

Indexed keywords

COMPLEMENTARY DNA; DRUG VEHICLE; GLYCERYL TRINITRATE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; ORGANIC NITRATE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BOLUS INJECTION; COMPLEX FORMATION; CONTROLLED STUDY; DNA DETERMINATION; DNA MICROARRAY; DOSE RESPONSE; DOWN REGULATION; DRUG INFUSION; DRUG MECHANISM; DRUG TOLERANCE; GENE EXPRESSION; GENE IDENTIFICATION; HEMODYNAMIC MONITORING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; THORACIC AORTA; UPREGULATION; ANIMAL; BLOOD PRESSURE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE DONORS; NITROGLYCERIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 0036451141     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9269.
2. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
3. Feelisch M. The use of nitric oxide donors in pharmacological studies. Naunyn Schmiedebergs Arch Pharmacol. 1998;358:113-122.
4. Tseng CM, Tabrizi-Fard MA, Fung HL. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. J Pharmacol Exp Ther. 2000;292:737-742.
5. Fung HL, Bauer JA. Mechanisms of nitrate tolerance. Cardiovasc Drugs Ther. 1994;8:489-499.
6. Needleman P, Johnson EM, Jr. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther. 1973;184:709-715.
7. Fung HL, Poliszczuk R. Nitrosothiol and nitrate tolerance. Z Kardiol. 1986;75:25-27.
8. Axelsson KL, Andersson RG. Tolerance towards nitroglycerin, induced in vivo, is correlated to a reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol. 1983;88:71-79.
9. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG. Evidence for enhanced vascular superoxide anion production in nitrate tolerance: a novel mechanism underlying tolerance and cross-tolerance. J Clin Invest. 1995;95:187-194.
10. Munzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci USA. 1995;92:5244-5248.
11. Munzel T, Li H, Mollnau H, et al. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res. 2000;86:E7-E12.
12. Lander ES. Array of hope. Nat Genet. 1999;21:3-4.
13. Taniguchi M, Miura K, Iwao H, Yamanaka S. Quantitative assessment of DNA microarrays--comparison with Northern blot analyses. Genomics. 2001;71:34-39.
14. Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 1998;391:169-173.
15. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D, Gaston B. S-nitrosothiols signal the ventilatory response to hypoxia. Nature. 2001;413:171-174.
16. Kowaluk EA, Poliszczuk R, Fung HL. Tolerance to relaxation in rat aorta: comparison of an S-nitrosothiol with nitroglycerin. Eur J Pharmacol. 1987;144:379-383.
17. Bauer JA, Fung HL. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther. 1991;256:249-254.
18. Matsumoto T, Takahashi M, Nakae I, Kinoshita M. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin. J Pharmacol Exp Ther. 1995;275:1247-1253.
19. Schuchhardt J, Beule D, Malik A, et al. Normalization strategies for cDNA microarrays. Nucleic Acids Res. 2000;28:E47:i-v.
20. Lee ML, Kuo FC, Whitmore GA, Sklar J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci USA. 2000;97:9834-9839.
21. Good P. Resampling Methods: A Practical Guide to Data Analysis. New York, NY: Springer-Verlag; 1999.
22. Edgington E. Randonization Tests. New York, NY: Marcel Dekker, Inc.; 1980.
23. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985;39:783-791.
24. Excoffier L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics. 1992;131:479-491.
25. Carpenter J, Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat Med. 2000;19:1141-1164.
26. Westfall PH, Young SS. Resampling-based Multiple Testing: Examples and Methods for p-adjustment. New York, NY: Wiley; 1993.
27. Kerr MK, Churchill GA. Bootstrapping cluster analysis: assessing the reliability of conclusions from microarray experiments. Proc Natl Acad Sci USA. 2001;98:8961-8965.
28. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001;98:5116-5121.
29. Herwig R, Aanstad P, Clark M, Lehrach H. Statistical evaluation of differential expression on cDNA nylon arrays with replicated experiments. Nucleic Acids Res. 2001;29:E117:1-9.
30. Kowaluk EA, Fung HL. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther. 1990;255:1256-1264.
31. Liu L, Hausladen A, Zeng M, Que L, Heitman J, Stamler JS. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 2001;410:490-494.
32. Yamamoto T, Bing RJ. Nitric oxide donors. Proc Soc Exp Biol Med. 2000;225:200-206.
33. Miller RA, Galecki A, Shmookler-Reis RJ. Interpretation, design, and analysis of gene array expression experiments. J Gerontol A Biol Sci Med Sci. 2001;56:B52-57.
34. Dudoit S, Yang YH, Callow M, Speed T. Statistical methods for identifying differentially expressed genes in replicated cDNA microarry experiments. UC Berkeley, Technical report #578, 2000.
35. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solution. J Cardiovasc Pharmacol. 1991;17:S25-S33.
36. Bennett BM, McDonald BJ, Nigam R, Simon WC. Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends Pharmacol Sci. 1994;15:245-249.
37. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci USA. 2001;98:9050-9055.
38. Huber A, Neuhuber WL, Klugbauer N, Ruth P, Allescher HD. Cysteine-rich protein 2, a novel substrate for cGMP kinase I in enteric neurons and intestinal smooth muscle. J Biol Chem. 2000;275:5504-5511.
39. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000;20:1430-1442.
40. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999;85:753-766.
41. Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK. Ceruloplasmin and cardiovascular disease. Free Radic Biol Med. 2000;28:1735-1744.
42. Floris G, Medda R, Padiglia A, Musci G. The physiopathological significance of ceruloplasmin: a possible therapeutic approach. Biochem Pharmacol. 2000;60:1735-1741.
43. Meininger CJ, Marinos RS, Hatakeyama K, et al. Impaired nitric oxide production in coronary endothelial cells of the spontaneously diabetic BB rat is due to tetrahydrobiopterin deficiency. Biochem J. 2000;349:353-356.